Abstract
Drug attitude inventory (DAI-30) is considered to be the best predictor of poor adherence in first-episode schizophrenia. We compared the short version (DAI-10) with DAI-30 in long-term schizophrenia, documented if DAI was associated with poor insight, PANSS and GAF and constructed DAI-10 percentiles. DAI-30 and DAI-10 were homogenous (r = 0.82 and 0.72, respectively) with good test-retest reliability (0.79). The correlation between the DAI versions was high (0.94). Percentile scores of DAI-10 were computed. DAI is an easy-to-use self-report instrument seemingly assessing a unique clinical dimension relevant to non-adherence. DAI-10 might be preferred for its simplicity and good psychometric properties.
Copyright © 2012 Elsevier B.V. and ECNP. All rights reserved.
Publication types
-
Comparative Study
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adult
-
Antipsychotic Agents / administration & dosage*
-
Antipsychotic Agents / therapeutic use
-
Attitude to Health*
-
Clozapine / administration & dosage
-
Clozapine / therapeutic use
-
Cognitive Science / methods
-
Drug Therapy, Combination
-
Female
-
Humans
-
Imidazoles / administration & dosage
-
Imidazoles / therapeutic use
-
Indoles / administration & dosage
-
Indoles / therapeutic use
-
Male
-
Medication Adherence*
-
Middle Aged
-
Pharmacology, Clinical / methods
-
Psychiatric Status Rating Scales*
-
Psychometrics / methods
-
Reproducibility of Results
-
Schizophrenia / drug therapy*
-
Schizophrenia / physiopathology
-
Schizophrenic Psychology
-
Self Report
-
Work Simplification
Substances
-
Antipsychotic Agents
-
Imidazoles
-
Indoles
-
sertindole
-
Clozapine